↓ Skip to main content

Cochrane Database of Systematic Reviews

Pharmacologic treatment for memory disorder in multiple sclerosis

Overview of attention for article published in this source, October 2011
Altmetric Badge

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
60 Mendeley
Title
Pharmacologic treatment for memory disorder in multiple sclerosis
Published by
John Wiley & Sons, Ltd, October 2011
DOI 10.1002/14651858.cd008876.pub2
Pubmed ID
Authors

He, Dian, Zhou, Hongyu, Guo, Duan, Hao, Zilong, Wu, Bo

Abstract

Memory disorder is one of the most frequent cognitive impairment and has a great negative impact on the quality of life in patients with multiple sclerosis (MS). A few pharmacologic agents appear to be effective to memory disorder in patients with MS in some existing randomised controlled trials.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Unknown 59 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 18%
Researcher 11 18%
Other 7 12%
Student > Doctoral Student 5 8%
Student > Bachelor 5 8%
Other 8 13%
Unknown 13 22%
Readers by discipline Count As %
Medicine and Dentistry 19 32%
Neuroscience 6 10%
Nursing and Health Professions 6 10%
Agricultural and Biological Sciences 4 7%
Psychology 4 7%
Other 5 8%
Unknown 16 27%